Crinetics Pharmaceuticals’ Post

View organization page for Crinetics Pharmaceuticals, graphic

18,876 followers

Our CEO & Founder, R Scott Struthers, is an EY Entrepreneur Of The Year® 2024 Pacific Southwest Award winner! Scott’s visionary approach to transforming the lives of those impacted by endocrine-related disorders has earned him this prestigious honor. He joins an esteemed multi-industry community of other entrepreneurs who have driven their companies’ success, transformed their industries, and made a positive impact on their employees and communities! Let's celebrate this well-deserved recognition of Scott's leadership and our collective efforts that made this achievement possible. #EOYUS #EOYPACSW Learn more here: https://bit.ly/3VNrDzs

  • No alternative text description for this image
Scott Thacher

CEO of Orphagen Pharmaceuticals

3mo

The award is VERY well-deserved. I have had the privilege to watch Crinetics from its very earliest days. And Scott has always been generous with his time with other entrepreneurs.

Isaac Mehl, PhD 梅睿鹏

Co-Founder @ Pi-Labs | Lab Operations Advisor and Builder

3mo

scott you are a god of san diego innovation. mazletof!

Fantastic and so well deserved!!

Traci Hardin

Certified Asthma Educator/Rare Disease Patient Advocate

3mo

Congratulations! Well deserved

Like
Reply
Adrienne Day

Life Sciences Business Development Consultant

3mo

Congratulations Scott well deserved

Like
Reply
Ryan Cornwell

Connecting Life Science

3mo

Congratulations R Scott Struthers and the Crinetics Pharmaceuticals team 👏🏻

Like
Reply
Sarah Boyce

President and CEO at Avidity Biosciences, Inc.

3mo

Congratulations Scott, very well deserved.

J D Faccinetti

Co-Founder Pituitary World News

3mo

Congratulations Scott!! Very well deserved! Thank you for all the amazing work you do.

Linda Sierra

Biotech/Life Sciences Executive Search, DE&I, Latina Executive. SVP, BD & Co-Chair DE&I

3mo

Wow, that’s a great award. Congratulations Scott!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics